Professional Documents
Culture Documents
Pathology of Gastric Cancer
Pathology of Gastric Cancer
Pathology of Gastric Cancer
Nardos Mulu(SR1)
Moderator – Dr. Hailu Wondimu
(Asst Professor of surgery)
July 22, 2020
Outline
• Introduction
• Epidemiology
• Risk factor
• Precancerous conditions
• Classification
• Staging
• Clinical manifestations
• References
Intro
• Most common malignant gastric neoplasm
(95%) is adenocarcinoma
• GIST, Lymphoma, NEC, …….
• Primary Vs secondary
Epidemiology
• 4th leading CA and 2nd leading cause of death
• Male Vs female
• Age – 69yrs; young pts
• Race: Asian
• Survival: 15% and 27%
Gastric carcinoma at Tikur Anbessa Hospital, Addis Ababa
O Johnson 1 , T Ersumo, A Ali
Risk factors
•* diet
•* smocking
•* H. Pylori (3x)
•* EBV (10%)
•* previous gastric surgery
Acquired
* BG A
* pernicious anemia
* family history (2-3x)
* FAP
* HNPCC
* Li Fraumani
Genetic
Precancerous lesions: polyps
• Asymptomatic (90%)
1. Gastric fundic – sporadic Vs ass. With FAP
2. Inflammatory or hyperplastic – 75%
3. Hemartomatous – juvenile, PJS, Cowden’s
4. Adenomatous – 6-10%
Precancerous cont.
• Atrophic gastritis
• Intestinal metaplasia
• Gastric ulcer
• Gastric remnant
Classification
Lauren classification (intestinal type (53%), diffuse type (33%), and unclassified (14%))
Staging
Clinical
• Location: distal (40%), middle (30%),
proximal (30%)
• Late presentation
• Early gastric ca
Symptoms
Signs
Prognosis
• Depth of invasion
• Nodal status
• Grade
• HER2
• 24 Vs 8Vs 5
Screening
• High risk population
• Hereditary syndromes
• EGD